Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionFulcrum Capital LLC
Latest Disclosed Ownership48,300 shares
Latest Disclosed Value $ 4,958,964
Fulcrum Capital LLC reports 0.65% decrease in ownership of ABL / Abbott Laboratories

On April 30, 2026 - Fulcrum Capital LLC filed a 13F-HR form disclosing ownership of 48,300 shares of Abbott Laboratories (DE:ABL) valued at $4,290,006 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 48,618 shares of Abbott Laboratories. This represents a change in shares of -0.65% during the quarter. The current value of the position is $3,633,126 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 48,300 -318 -0.65 4,959 -18.60 1.0765
2026-01-15 2025-12-31 13F ABBOTT LABS COM 002824100 48,618 1,444 3.06 6,091 -3.59 1.2233
2025-10-28 2025-09-30 13F ABBOTT LABS COM 002824100 47,174 536 1.15 6,318 -0.39 1.2955
2025-07-24 2025-06-30 13F ABBOTT LABS COM 002824100 46,638 890 1.95 6,343 4.53 1.3417
2025-04-08 2025-03-31 13F ABBOTT LABS COM 002824100 45,748 1,089 2.44 6,068 20.13 1.3453
2025-01-13 2024-12-31 13F ABBOTT LABS COM 002824100 44,659 1,040 2.38 5,051 1.57 1.0578
2024-10-22 2024-09-30 13F ABBOTT LABS COM 002824100 43,619 673 1.57 4,973 11.45 1.0832
2024-07-22 2024-06-30 13F ABBOTT LABS COM 002824100 42,946 1,549 3.74 4,462 -5.16 1.0161
2024-04-17 2024-03-31 13F ABBOTT LABS COM 002824100 41,397 995 2.46 4,705 5.80 1.1167
2024-01-10 2023-12-31 13F ABBOTT LABS COM 002824100 40,402 2,557 6.76 4,447 21.34 1.1499
2023-10-13 2023-09-30 13F ABBOTT LABS COM 002824100 37,845 -16,677 -30.59 3,665 -38.33 1.0640
2023-07-27 2023-06-30 13F ABBOTT LABS COM 002824100 54,522 -2,315 -4.07 5,944 3.27 1.5632
2023-05-11 2023-03-31 13F ABBOTT LABS COM 002824100 56,837 3,152 5.87 5,755 -2.36 1.5493
2023-01-24 2022-12-31 13F ABBOTT LABS COM 002824100 53,685 4,236 8.57 5,894 23.18 1.7033
2022-10-17 2022-09-30 13F ABBOTT LABS COM 002824100 49,449 -125 -0.25 4,785 -11.16 1.4212
2022-08-03 2022-06-30 13F ABBOTT LABS COM 002824100 49,574 -20,555 -29.31 5,386 -45.43 1.6928
2022-01-25 2021-12-31 13F ABBOTT LABS COM 002824100 70,129 3,300 4.94 9,870 25.02 2.1403
2021-10-21 2021-09-30 13F ABBOTT LABS COM 002824100 66,829 2,520 3.92 7,895 5.90 1.8888
2021-07-30 2021-06-30 13F ABBOTT LABS COM 002824100 64,309 4,385 7.32 7,455 3.82 1.8704
2021-04-12 2021-03-31 13F ABBOTT LABS COM 002824100 59,924 -805 -1.33 7,181 8.00 2.0594
2021-02-09 2020-12-31 13F ABBOTT LABS COM 002824100 60,729 546 0.91 6,649 1.51 1.9888
2020-10-21 2020-09-30 13F ABBOTT LABS COM 002824100 60,183 -8,025 -11.77 6,550 5.04 2.3691
2020-07-27 2020-06-30 13F ABBOTT LABS COM 002824100 68,208 -4,113 -5.69 6,236 9.27 2.3633
2020-05-01 2020-03-31 13F ABBOTT LABS COM 002824100 72,321 -1,635 -2.21 5,707 -11.16 2.5906
2020-02-03 2019-12-31 13F ABBOTT LABS COM 002824100 73,956 2,047 2.85 6,424 6.76 1.9892
2019-11-01 2019-09-30 13F/A-1 Abbott Laboratories COM 002824100 71,909 2,658 3.84 6,017 3.31 2.0548
2019-10-31 2019-09-30 13F Abbott Laboratories COM 002824100 71,909 2,658 12,482 4.3773
2019-07-29 2019-06-30 13F Abbott Laboratories COM 002824100 69,251 3,825 5.85 5,824 11.36 2.1320
2019-05-08 2019-03-31 13F ABBOTT LABS COM 002824100 65,426 2,535 4.03 5,230 14.97 1.9751
2019-02-12 2018-12-31 13F ABBOTT LABS COM 002824100 62,891 -1,391 -2.16 4,549 -3.54 2.0497
2018-11-05 2018-09-30 13F ABBOTT LABS COM 002824100 64,282 -126 -0.20 4,716 20.06 1.8388
2018-08-03 2018-06-30 13F ABBOTT LABS COM 002824100 64,408 -499 -0.77 3,928 1.00 1.8753
2018-05-09 2018-03-31 13F ABBOTT LABS COM 002824100 64,907 -1,676 -2.52 3,889 2.34 1.2662
2018-01-30 2017-12-31 13F ABBOTT LABORATORIES COM 002824100 66,583 66,583 3,800 1.2321
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.